The first clinical trial of an antiviral drug's effectiveness in people exposed to the deadly Ebola strain spreading in the Democratic Republic of Congo is underway, the WHO said Tuesday.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗